Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Kohane

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Endocrinology|February 1, 1994
Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestationR L Emanuel, B G Robinson, E W Seely, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
Alimentary Pharmacology & Therapeutics|March 20, 2014
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, V S Gainer, et al.
Clinical Pharmacology and Therapeutics|May 27, 2011
Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levelsN P Tatonetti, J C Denny, S N Murphy, et al.
Alimentary Pharmacology & Therapeutics|January 8, 2013
Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's diseaseA N Ananthakrishnan, V S Gainer, R G Perez, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Endocrinology|February 1, 1994
Corticotrophin releasing hormone levels in human plasma and amniotic fluid during gestationR L Emanuel, B G Robinson, E W Seely, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, T Cai, et al.
Alimentary Pharmacology & Therapeutics|March 20, 2014
Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseasesA N Ananthakrishnan, A Cagan, V S Gainer, et al.
Clinical Pharmacology and Therapeutics|May 27, 2011
Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levelsN P Tatonetti, J C Denny, S N Murphy, et al.
Alimentary Pharmacology & Therapeutics|January 8, 2013
Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's diseaseA N Ananthakrishnan, V S Gainer, R G Perez, et al.
Pageof 2